Would you restart an insulin drip in a patient with metabolic acidosis, as indicated by a bicarbonate level of 15 and an anion gap of 14?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Decision on Restarting Insulin Drip

No, do not restart an insulin drip for a patient with bicarbonate 15 and anion gap 14, as this represents a non-anion gap metabolic acidosis without evidence of diabetic ketoacidosis. 1

Critical Assessment Required

The laboratory values provided do not indicate diabetic ketoacidosis (DKA), which is the primary indication for continuous insulin infusion:

  • Anion gap of 14 is normal (normal range 8-12 mEq/L, with 14 being borderline-normal depending on laboratory reference ranges) 1
  • DKA requires an elevated anion gap (typically >12 mEq/L) along with ketonemia/ketonuria, pH <7.3, and bicarbonate <18 mEq/L 1, 2
  • This patient's bicarbonate of 15 mEq/L with a normal anion gap suggests hyperchloremic (non-anion gap) metabolic acidosis, not ketoacidosis 3

Essential Missing Information

Before making any insulin decision, you must obtain:

  • Blood glucose level - insulin drips are contraindicated if glucose is normal or low 1, 4
  • Serum or urine ketones (beta-hydroxybutyrate >3.0 mmol/L or ketonuria ≥2+) - absence excludes DKA 1, 2
  • Arterial or venous pH - DKA requires pH <7.3 1, 2
  • Serum potassium - insulin drip is absolutely contraindicated if K+ <3.3 mEq/L due to risk of fatal arrhythmias 1, 5
  • Clinical context - recent SGLT2 inhibitor use, infection, decreased oral intake, or other precipitants 6, 4, 7

When Insulin Drip IS Indicated

Continuous intravenous insulin infusion is recommended only when all of the following DKA criteria are met 1, 2:

  • Blood glucose >250 mg/dL (though euglycemic DKA can occur with glucose <200 mg/dL, particularly with SGLT2 inhibitors) 6, 4, 7
  • Serum bicarbonate <18 mEq/L 1, 2
  • Anion gap >12 mEq/L 1, 2
  • pH <7.3 1, 2
  • Positive ketones (serum beta-hydroxybutyrate ≥3.0 mmol/L or urine ketones ≥2+) 1, 2
  • Serum potassium ≥3.3 mEq/L 1, 5

Alternative Causes of Low Bicarbonate with Normal Anion Gap

The presentation of bicarbonate 15 with anion gap 14 suggests 3:

  • Gastrointestinal bicarbonate loss (diarrhea, ileostomy, ureterosigmoidostomy)
  • Renal tubular acidosis
  • Early renal failure
  • Drug-induced hyperkalemia (check potassium level)
  • Administration of acids or excessive normal saline

These conditions do not require insulin drip therapy 3.

Critical Pitfall to Avoid

Never start an insulin drip based solely on low bicarbonate without confirming elevated anion gap, hyperglycemia, and ketosis. 1, 2 Starting insulin in a patient with normal or low glucose, or with potassium <3.3 mEq/L, can cause life-threatening hypoglycemia or cardiac arrhythmias 1, 5.

Appropriate Management Instead

For non-anion gap metabolic acidosis with bicarbonate 15 3:

  • Identify and treat the underlying cause (GI losses, renal dysfunction, medications)
  • Ensure adequate hydration with isotonic fluids
  • Monitor electrolytes closely, particularly potassium
  • Consider bicarbonate replacement only if pH <7.1 or bicarbonate <10 mEq/L with hemodynamic instability
  • Continue basal subcutaneous insulin if the patient has diabetes, but do not use IV insulin drip 8

References

Guideline

Diabetic Ketoacidosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Type 1 Diabetes with Subcutaneous Insulin When Urine Ketones Are Positive

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metabolic acidosis.

Acta medica Indonesiana, 2007

Research

Euglycemic diabetic ketoacidosis.

European journal of internal medicine, 2019

Guideline

Insulin Dosing for Type 2 Diabetes with DKA and Infected Foot Ulcer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.